Evidence map›Paper›PMID 40643912›Full record

ArticleJAMA network open2025

Use of Tobacco and Cannabis Following State-Level Cannabis Legalization.

Andrew S Hyatt, Lindsay Overhage, Benjamin Lê Cook

Abstract read
In one paragraph

Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrew S HyattHealth Equity Research Lab, Cambridge Health Alliance, Cambridge, Massachusetts.
Lindsay OverhageHealth Equity Research Lab, Cambridge Health Alliance, Cambridge, Massachusetts.
Benjamin Lê CookHealth Equity Research Lab, Cambridge Health Alliance, Cambridge, Massachusetts.

Funding

Medical Scientist Training ProgramT32GM144273 · NIGMS · HARVARD MEDICAL SCHOOL · PI David Shumway Jones, Jacqueline A. Lees · 2022 to 2026
$14.7M
Health Policy Training Program: Promoting Outcomes, Quality, Equity and Diffusion of AdvancesT32MH019733 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Benjamin Le Cook, Haiden A Huskamp · 1993 to 2026
$7.0M
Understanding the Role of Trauma Over the Lifecourse in Order to Improve Trauma-informed TreatmentP50MH126283 · NIMH · CAMBRIDGE HEALTH ALLIANCE · PI WEISS, MARGARET · 2021 to 2024
$6.6M
MD-PhD Training Program in Aging and the Social/Behavioral SciencesT32AG051108 · NIA · HARVARD MEDICAL SCHOOL · PI MCWILLIAMS, JOHN MICHAEL · 2015 to 2025
$2.1M
Impact of cannabis legalization and commercialization on substance use and mental health outcomes in psychosisK23DA062173 · NIDA · CAMBRIDGE HEALTH ALLIANCE · PI Andrew Hyatt · 2025 to 2026
$354k
AHRQ HHS R01 HS021486NIA NIH HHS T32 AG051108NIDA NIH HHS K23 DA062173NIGMS NIH HHS T32 GM144273NIMH NIH HHS P50 MH126283NIMH NIH HHS T32 MH019733
6 · The paper itself

Abstract

Importance: Cannabis use has been shown to modestly increase shortly after legalization of recreational use, but little is known about longer-term changes in cannabis and tobacco use. Objective: To assess the association of cannabis legalization and commercialization with the use of cannabis, cigarettes, and electronic nicotine delivery systems (ENDS) in the 5 years after legalization in the US. Design, Setting, and Participants: The Population Assessment of Tobacco and Health (PATH) study, a nationally representative longitudinal cohort study of adults 18 years or older in the US, was used for a retrospective, difference-in-differences analysis of panel data from January 2013 to December 2022. Data were analyzed from May 8, 2024, to April 20, 2025. Exposures: State-level recreational cannabis legalization (RCL) and opening of retail outlets with 5 years of follow-up. Main Outcomes and Measures: Percentage point changes in 30-day use of cannabis, cigarettes, and ENDS in states with legalization compared with control states, aggregated over 5 years and then broken down into the periods before and after retail outlets opened. Results: Among the 171 257 observations from 55 406 individuals included in the analysis (50.9% female; mean [SD] age, 37.97 [17.69] years), RCL was associated with an increase of cannabis use by 3.28 (95% CI, 2.29-4.27) percentage points and ENDS use by 1.39 (95% CI, 0.44-2.35) percentage points compared with control states. There was no differential change in cigarette use (-0.99 [95% CI, -2.25 to 0.27] percentage points). For cannabis, this change was greater after retail outlets opened (3.74 [95% CI, 2.65-4.82] percentage points) compared with before (1.17 [95% CI, 0.13-2.20] percentage points). There were no large changes in ENDS or cigarette use associated with the opening of retail outlets. Conclusions and Relevance: In this longitudinal cohort study, RCL was associated with more cannabis and ENDS use after 5 years and no significant change in cigarette use. Furthermore, cannabis use increased over time, underscoring the importance of studying commercialization policy going forward. Based on the present results, it is unlikely RCL has been associated with a large increase in cigarette use, but increases in use of cannabis and vaped nicotine bear close monitoring as retail cannabis rapidly expands.

Indexed as

Legislation, DrugMarijuana SmokingMarijuana UseTobacco ProductsTobacco UseAdolescentAdultCannabisElectronic Nicotine Delivery SystemsFemaleHumansLongitudinal StudiesMaleMiddle AgedRetrospective StudiesUnited States

Identifiers

PMID40643912
PMCPMC12254894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.